PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26136531-5	2015	Atropine blocked muscarinic, cholinergic transmission, as evidenced by an increase in heart rate [peak: 70 +- 2 (saline) vs. 90 +- 2 (atropine) beats/min, P < 0.002] and suppression of pancreatic polypeptide levels [area under the curve during the GLP-1 infusions (AUC45-145): 492 +- 85 (saline) vs. 247 +- 59 (atropine) pmol/l x min, P < 0.0001].	Atropine	0-8	glucagon	Homo sapiens	251-256	
26136531-9	2015	Atropine suppressed glucagon levels additively with GLP-1 [AUC45-145: 469 +- 70 (saline) vs. 265 +- 50 (atropine) pmol/l x min, P = 0.018], resulting in hypoglycemia when infusions were suspended [3.6 +- 0.2 (saline) vs. 2.7 +- 0.2 (atropine) mmol/l, P < 0.0001].	Atropine	233-241	glucagon	Homo sapiens	52-57	
31446595-0	2019	In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review.	Atropine	43-51	glucagon	Homo sapiens	76-99	
25486965-8	2015	Single administration of miglitol triggered no GLP1 secretion, and GLP1 secretion by miglitol plus maltose was significantly attenuated by atropine pretreatment, suggesting regulation via vagal nerve.	Atropine	139-147	glucagon	Homo sapiens	67-71	
9062483-5	1997	With all methods a pulsatile pattern of plasma GLP-1 levels with a frequency of five to seven per h was detected; this remained unchanged in the different metabolic states and during atropine treatment.	Atropine	183-191	glucagon	Homo sapiens	47-52	
9062483-6	1997	Glucose and GLP-1 plasma levels showed a parallel increase after OGL (OGL without atropine = control: 8.4 +/- 2.9 and 7.9 +/- 3.0 min, respectively).	Atropine	82-90	glucagon	Homo sapiens	12-17	
9062483-8	1997	In contrast to plasma glucose concentrations (82.7 +/- 0.3% of control; P < 0.05), atropine infusion reduced the integrated GLP-1 pulse amplitude to 56.0 +/- 11.3% of the control levels (P < 0.05).	Atropine	86-94	glucagon	Homo sapiens	127-132	
9062483-11	1997	The differential effect of atropine on glucose and GLP-1 plasma levels suggest a direct cholinergic muscarinic control of L cells.	Atropine	27-35	glucagon	Homo sapiens	51-56	
31446595-4	2019	This review explores studies that assess the role of atropine in GLP-1 secretion.	Atropine	53-61	glucagon	Homo sapiens	65-70	
31446595-12	2019	Majority of the studies reported an atropine-mediated attenuation of GLP-1 secretion and postprandial secretion of GLP-1 was mainly affected.	Atropine	36-44	glucagon	Homo sapiens	69-74	
31446595-12	2019	Majority of the studies reported an atropine-mediated attenuation of GLP-1 secretion and postprandial secretion of GLP-1 was mainly affected.	Atropine	36-44	glucagon	Homo sapiens	115-120